A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 47/48 (2006.01) A61K 31/19 (2006.01) A61K 31/215 (2006.01) A61K 45/08 (2006.01) C07F 9/10 (2006.01)
Patent
CA 2159610
The invention relates to a pharmaceutically acceptable prodrug which is a covalent conjugate of a pharmacologically active compound and an intracellular transporting adjuvant, characterized by the presence of a covalent bond which is scission-sensitive to intracellular enzyme activity. The prodrug may be used in a technique for treating a condition or disease in a human related to supranormal intracellular enzyme (e.g. phospholipase and/or esterase) activity, whereby on administering it to a human having such condition or disease, the bond is broken in response to such activity, and the pharmacologically active compound accumulates selectively within cells having such supranormal intracellular enzyme activity. Exemplary conjugates are esters of the carboxylic function in the formula, with e.g. heptanoyl-sn-3--glycerophosphoryl-choline or octanoyl-sn-3-glycerophosphoryl- choline.
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
D-Pharm Ltd.
LandOfFree
Prodrugs with enhanced penetration into cells does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Prodrugs with enhanced penetration into cells, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prodrugs with enhanced penetration into cells will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2091883